Breaking News Instant updates and real-time market news.

ARRY

Array BioPharma

$23.11

-0.06 (-0.26%)

08:08
05/07/19
05/07
08:08
05/07/19
08:08

Array BioPharma reports Q3 EPS (17c), consensus (20c)

Reports Q3 revenue $64.7M, consensus $54.04M. Reports cash, cash equivalents and marketable securities as of March 31 $479M.

  • 07

    May

  • 31

    May

ARRY Array BioPharma
$23.11

-0.06 (-0.26%)

01/15/19
CANT
01/15/19
INITIATION
Target $30
CANT
Overweight
Array BioPharma initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Varun Kumar started Array BioPharma with an Overweight rating and $30 price target. The stock currently trades at a "significant discount" as its lead asset, Mektovi plus Braftovi, still appears underappreciated by investors, Kumar tells investors in a research note. The analyst believes Array's MEK/BRAFi combination has a "best-in-class" profile and is well positioned commercially in BRAF-mutant melanoma and clinically in BRAF-mutant colorectal cancer.
01/17/19
LEER
01/17/19
INITIATION
Target $28
LEER
Outperform
Array BioPharma initiated with an Outperform at Leerink
Leerink analyst Thomas Smith started Array BioPharma with an Outperform rating and $28 price target. The analyst sees Braftovi and Mektovi as a best-in-class combination launching into a $1B global market for the treatment of BRAF+ melanoma, with near-term potential to expand into BRAF+ colorectal cancer, where there is limited competition. Smith also sees a favorable catalyst path for shares through 2019, and believes the company is well-positioned to benefit from the recent resurgence of M&A in the targeted oncology sector.
02/05/19
PIPR
02/05/19
NO CHANGE
Target $28
PIPR
Overweight
Piper raises U.S. sales forecast for Array based on 'strong' quarter, Rx trends
Piper Jaffray analyst Edward Tenthoff noted that Array Biopharma (ARRY) reported Q2 MEKTOVI and BRAFTOVI sales of $22.7M that beat his and the consensus forecast. Management "importantly" commented that doctors are switching patients from Novartis' (NVS) doublet Mekinist + Tafinlar, said Tenthoff, who also noted that total prescriptions doubled to 2,600 from 1,300 in the first quarter of launch. Following the report and call, Tenthoff raised his U.S. sales forecast for calendar 2019 to $117M and keeps an Overweight rating on Array shares with a $28 price target.
03/14/19
JPMS
03/14/19
NO CHANGE
Target $29
JPMS
Overweight
Array BioPharma price target raised to $29 from $18 at JPMorgan
JPMorgan analyst Anupam Rama raised his price target for Array BioPharma to $29 from $18 and reiterates an Overweight rating on the shares. The analyst believes the company's fundamentals "remain very solid." The Braftovi / Mektovi launch in BRAF melanoma has exceeded expectations and the interim Phase 3 Beacon study has a high probability of success, Rama tells investors in a research note. Further, the analyst says recent conversations with physicians have reinforced his positive views on Braftovi / Mektovi in melanoma. He sees a favorable risk/reward into the Phase 3 Beacon study.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$108.61

-0.39 (-0.36%)

, HD

Home Depot

$192.49

-0.04 (-0.02%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$108.61

-0.39 (-0.36%)

HD

Home Depot

$192.49

-0.04 (-0.02%)

AMZN

Amazon.com

$1,851.99

-16.33 (-0.87%)

SHLD

Sears

$0.00

(0.00%)

JCP

J.C. Penney

$1.11

-0.035 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 24

    Jun

TSLA

Tesla

$199.00

-12.02 (-5.70%)

, TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Tesla dips below $200 as analysts voice concern over Model 3 demand »

Shares of Tesla (TSLA)…

TSLA

Tesla

$199.00

-12.02 (-5.70%)

TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

VRNA

Verona Pharma

$5.90

-0.45 (-7.09%)

10:20
05/20/19
05/20
10:20
05/20/19
10:20
Hot Stocks
Verona Pharma presents expanded analysis of ensifentrine clinical data »

Verona Pharma presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$19.26

-0.38 (-1.93%)

, TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Hot Stocks
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment »

Theravance Biopharma…

MYL

Mylan

$19.26

-0.38 (-1.93%)

TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Conference/Events
Wolfe Research IT hardware analyst to hold an analyst/industry conference call »

IT Hardware &…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

, OSW

OneSpaWorld

$13.55

0.05 (0.37%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

OSW

OneSpaWorld

$13.55

0.05 (0.37%)

ZM

Zoom Video

$86.55

-3.36 (-3.74%)

BYND

Beyond Meat

$88.70

-0.63 (-0.71%)

FMC

FMC Corporation

$74.01

-1.24 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

AAL

American Airlines

$30.38

-1.38 (-4.35%)

, DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

AAL

American Airlines

$30.38

-1.38 (-4.35%)

DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

DB

Deutsche Bank

$7.42

-0.16 (-2.11%)

EV

Eaton Vance

$36.91

-0.895 (-2.37%)

PRA

ProAssurance

$38.42

-0.72 (-1.84%)

CLX

Clorox

$147.09

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 12

    Jun

  • 20

    Jun

GD

General Dynamics

$169.82

3.43 (2.06%)

, TGT

Target

$71.62

0.74 (1.04%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

GD

General Dynamics

$169.82

3.43 (2.06%)

TGT

Target

$71.62

0.74 (1.04%)

NPTN

NeoPhotonics

$3.99

0.16 (4.18%)

UAL

United Continental

$81.40

-0.12 (-0.15%)

JACK

Jack in the Box

$82.09

-0.13 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 22

    May

  • 28

    May

  • 29

    May

  • 04

    Jun

  • 12

    Jun

  • 25

    Jun

  • 27

    Jun

  • 08

    Aug

TRN

Trinity Industries

$20.78

-0.15 (-0.72%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Hot Stocks
Trinity Industries announces strategic railcar maintenance network expansion »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/20/19
05/20
10:16
05/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
05/20/19
05/20
10:15
05/20/19
10:15
Conference/Events
Wolfe Research healthcare analyst to hold analyst/industry conference call »

Healthcare Services…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Fed's Harker didn't discuss policy or the economy »

Fed's Harker…

10:10
05/20/19
05/20
10:10
05/20/19
10:10
General news
U.S. corporate bond update: several issues are on the docket »

U.S. corporate bond…

FLIC

First Long Island

$22.31

(0.00%)

10:04
05/20/19
05/20
10:04
05/20/19
10:04
Hot Stocks
First Long Island names Janet Verneuille EVP, CRO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSC

Studio City

$17.00

(0.00%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Studio City falls -7.3% »

Studio City is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$3.40

-0.26 (-7.10%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Barnes & Noble Education falls -7.7% »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$73.76

-8.12 (-9.92%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Keysight Technologies falls -9.8% »

Keysight Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SMI

SMIC

$5.39

0.38 (7.58%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
SMIC rises 7.6% »

SMIC is up 7.6%, or 38c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBK

Westpac Banking

$18.98

1.63 (9.39%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Westpac Banking rises 9.2% »

Westpac Banking is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$7.64

1.46 (23.64%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Sprint rises 23.5% »

Sprint is up 23.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.83

-0.49 (-1.31%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Boston Scientific to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

UNM

Unum Group

$34.79

-0.01 (-0.03%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Unum Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 23

    May

  • 11

    Jun

RDY

Dr. Reddy's

$36.93

-2.38 (-6.05%)

09:47
05/20/19
05/20
09:47
05/20/19
09:47
Hot Stocks
Dr. Reddy's falls -6.2% »

Dr. Reddy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.